Company Filing History:
Years Active: 2015
Title: Steven L. Swann: Innovator in Therapeutic Agents
Introduction
Steven L. Swann is a notable inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on isoxazolines. His research focuses on developing compounds that can effectively treat immunological conditions.
Latest Patents
Steven L. Swann holds a patent for "Isoxazolines as therapeutic agents." This invention provides a compound of Formula (I) that includes biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates, and pharmaceutically acceptable salts. The compounds described in this patent are designed to be useful in treating various immunological conditions.
Career Highlights
Steven is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on the development of innovative therapeutic solutions that address unmet medical needs.
Collaborations
Throughout his career, Steven has collaborated with esteemed colleagues, including David J. Calderwood and Eric C. Breinlinger. These collaborations have contributed to the advancement of research in the field of therapeutic agents.
Conclusion
Steven L. Swann's contributions to the field of therapeutic agents through his patent on isoxazolines highlight his role as an innovator in the medical research community. His work continues to pave the way for new treatments for immunological conditions.